SEC 13F Intelligence

Highlander Partners, L.P. / MIRM

Highlander Partners, L.P.’s Mirum Pharmaceuticals Inc Position

Does Highlander Partners, L.P. own Mirum Pharmaceuticals Inc (MIRM)? Yes — 123.0K shares worth $11M (+4.45% of its 13F portfolio) as of Q1 2026.

Position Value
$11M
Q1 2026
Shares
123.0K
% of Portfolio
+4.45%
Quarters Held
18
currently held

Position History MIRM

Reported value by quarter
Q4 ’21: $2MQ4 ’21Q1 ’22: $3MQ2 ’22: $2MQ3 ’22: $3MQ3 ’22Q4 ’22: $2MQ1 ’23: $3MQ2 ’23: $3MQ2 ’23Q3 ’23: $4MQ4 ’23: $4MQ1 ’24: $3MQ1 ’24Q2 ’24: $4MQ3 ’24: $5MQ4 ’24: $5MQ4 ’24Q1 ’25: $6MQ2 ’25: $6MQ3 ’25: $9MQ3 ’25Q4 ’25: $10MQ1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026123.0K$11M+4.45%
Q4 2025123.0K$10M+3.49%
Q3 2025123.0K$9M+3.14%
Q2 2025123.0K$6M+2.40%
Q1 2025123.0K$6M+3.43%
Q4 2024123.0K$5M+2.89%
Q3 2024123.0K$5M+2.83%
Q2 2024123.0K$4M+2.80%
Q1 2024123.0K$3M+2.14%
Q4 2023123.0K$4M+2.90%
Q3 2023123.0K$4M+3.84%
Q2 2023123.0K$3M+3.58%
Q1 2023123.0K$3M+4.00%
Q4 2022123.0K$2M+3.25%
Q3 2022123.0K$3M+3.84%
Q2 2022123.0K$2M+3.15%
Q1 2022123.0K$3M+3.40%
Q4 2021123.0K$2M+2.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highlander Partners, L.P.’s full portfolio or all institutional holders of MIRM.